| Catalog_no |
ADMC0126 |
| Product_name |
Dovitinib (TKI258) Lactate |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
880.00/3000.00/4880.00 |
| Specificity |
TargetTarget inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively. |
| Dilution |
|
| Purification |
99% |
| Concentration |
靶点：See reference;IC50：No data |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
TKI258,CHIR258,Dovitinib (TKI 258,CHIR 258) |
| Molecular Weight |
500.53 |
| Notes |
Dovitinib (TKI258, CHIR258) is a novel multi-target inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively. |
| Instructions |
 查看与下载 |
